Vylor Offers Pure Play Genetics Compounder, Oppenheimer Says
MT newswire2026/10/06 15:3611:36 AM EDT, 10/06/2026 (MT Newswires) -- Vylor (VYLR) is positioned as the only scaled pure-play seed and genetics company, with a strong germplasm library and top US corn and soybean brands, Oppenheimer said in a Tuesday note. The report said Vylor enters its first year as a standalone with some 27% operating EBITDA margins, and a licensing business that turns net positive in 2027 for the first time. "We see low-single-digit sales growth compounding into high-single-digit EBITDA growth, with gene editing and hybrid wheat as longer-dated options not in the numbers," the report said. The note pointed to improved cash flow visibility, favorable near-term setup, and scarcity value that support 18 times multiple. Oppenheimer initiated coverage of the stock with an outperform rating and an $82 price target. Price: 73.30, Change: -0.03, Percent Change: -0.04
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Jensen Huang's influence surpasses that of Nvidia— and that's exactly the problem
Jensen Huang has been the key driving force behind the massive expansion of AI infrastructure, with his personal credibility and authoritative decision-making deeply embedded in the narrative of the global tech market’s rise over the past three years. Now, as scandals emerge, Nvidia’s trading team is expected to become more conservative and slow down external financing commitments, which undoubtedly worsens the situation for neoclouds already facing tight funding.


Deutsche Bank made significant Q3 purchases of midstream AI application stocks: the three major cloud giants saw increased holdings, with Palantir (PLTR.US) and Salesforce (CRM.US) also favored.
Deutsche Bank has submitted its third quarter 13F holdings report for the period ending September 30, 2026.
